Cargando…
Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells
Radiotherapy (RT) plays an important role in localized lung cancer treatments. Although RT locally targets and controls malignant lesions, RT resistance prevents RT from being an effective treatment for lung cancer. In this study, we identified phosphomevalonate kinase (PMVK) as a novel radiosensiti...
Autores principales: | Park, Seok Soon, Kwon, Mi Ri, Ju, Eun Jin, Shin, Seol Hwa, Park, Jin, Ko, Eun Jung, Son, Ga Won, Lee, Hye Won, Kim, Yeon Joo, Moon, Gyeong Joon, Park, Yun‐Yong, Song, Si Yeol, Jeong, Seong‐Yun, Choi, Eun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475767/ https://www.ncbi.nlm.nih.gov/pubmed/37650703 http://dx.doi.org/10.1111/cas.15896 |
Ejemplares similares
-
NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer
por: Kwon, Mi Ri, et al.
Publicado: (2023) -
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
por: Shin, Seol Hwa, et al.
Publicado: (2023) -
Kinetics of Phosphomevalonate Kinase from Saccharomyces cerevisiae
por: Garcia, David E., et al.
Publicado: (2014) -
An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers
por: Shin, Seol Hwa, et al.
Publicado: (2021) -
Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases
por: Berner, Jakob, et al.
Publicado: (2023)